Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Nieuwdorp

Showing results (301-310 of 416) with videos related to

Pageof 42
Sort By:
Research Square|May 15, 2024
The gut microbiome modulates the impact of Anaerobutyricum soehngenii supplementation on glucose homeostasis in miceEvan R Hutchison, Mei-I Yen, Hubert W Peng, et al.
JCI Insight|July 11, 2023
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL productionVehpi Yildirim, Kasper W Ter Horst, Pim W Gilijamse, et al.
Diabetes|March 29, 2006
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetesMax Nieuwdorp, Hans L Mooij, Jojanneke Kroon, et al.
Diabetes, Obesity & Metabolism|February 7, 2020
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterolKristien E C Bouter, Erik J M van Bommel, Hans Jansen, et al.
Metabolism: Clinical and Experimental|June 13, 2021
Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesityMaria P Clemente-Olivo, Jayron J Habibe, Mariska Vos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2024
Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in HumansEmma C E Meessen, Soumia Majait, Ümran Ay, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|April 7, 2022
Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgeryMaimoena S S Guman, Sylke Haal, L Maurits de Brauw, et al.
The Lancet. Diabetes & Endocrinology|July 19, 2025
Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort studyCoco M Fuhri Snethlage, Paul Smeets, Pleun de Groen, et al.
Gut Microbes|October 6, 2025
Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetesPleun de Groen, Coco M Fuhri Snethlage, Koen Wortelboer, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 27, 2021
Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetesSuzanne Meiring, Emma C E Meessen, Annieke C G van Baar, et al.
Pageof 42

Showing results (301-310 of 416) with videos related to

Sort By:
Pageof 42
Research Square|May 15, 2024
The gut microbiome modulates the impact of Anaerobutyricum soehngenii supplementation on glucose homeostasis in miceEvan R Hutchison, Mei-I Yen, Hubert W Peng, et al.
JCI Insight|July 11, 2023
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL productionVehpi Yildirim, Kasper W Ter Horst, Pim W Gilijamse, et al.
Diabetes|March 29, 2006
Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetesMax Nieuwdorp, Hans L Mooij, Jojanneke Kroon, et al.
Diabetes, Obesity & Metabolism|February 7, 2020
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterolKristien E C Bouter, Erik J M van Bommel, Hans Jansen, et al.
Metabolism: Clinical and Experimental|June 13, 2021
Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesityMaria P Clemente-Olivo, Jayron J Habibe, Mariska Vos, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2024
Glycodeoxycholic Acid Inhibits Primary Bile Acid Synthesis With Minor Effects on Glucose and Lipid Homeostasis in HumansEmma C E Meessen, Soumia Majait, Ümran Ay, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|April 7, 2022
Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgeryMaimoena S S Guman, Sylke Haal, L Maurits de Brauw, et al.
The Lancet. Diabetes & Endocrinology|July 19, 2025
Sex-based disparities in perceived versus objective glycaemic control in type 1 diabetes: a cross-sectional cohort studyCoco M Fuhri Snethlage, Paul Smeets, Pleun de Groen, et al.
Gut Microbes|October 6, 2025
Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetesPleun de Groen, Coco M Fuhri Snethlage, Koen Wortelboer, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 27, 2021
Duodenal mucosal resurfacing with a GLP-1 receptor agonist increases postprandial unconjugated bile acids in patients with insulin-dependent type 2 diabetesSuzanne Meiring, Emma C E Meessen, Annieke C G van Baar, et al.
Pageof 42